SCHEMBL12878492

SCHEMBL12878492

CCC(C)c1cc(Nc2nc(-c3ccc(CNC(C)=O)s3)ncc2Cl)[nH]n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.38
▸ MAPT P10636 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ CCNA2 P20248 1/20 0.36
▸ CDK2 P24941 1/20 0.36
▸ NTRK1 P04629 5/20 0.34
▸ NPC1 O15118 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ JAK2 O60674 3/20 0.32
▸ AURKA O14965 2/20 0.32
▸ NTRK3 Q16288 2/20 0.32
▸ NTRK2 Q16620 2/20 0.32
▸ LCK P06239 1/20 0.32
▸ FYN P06241 1/20 0.32
▸ RET P07949 1/20 0.32
▸ IGF1R P08069 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1165046 0.82 CDK2 (0.46) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL12784885 0.76 CCNA2 (0.64) CCNA2CDK2NTRK1IGF1R
SCHEMBL12878562 0.74 CCNA2 (0.46) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL12784562 0.74 CCNA2 (0.46) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL12784539 0.68 CCNA2 (0.49) CCNA2CDK2NTRK1IGF1R
SCHEMBL12784877 0.67 CCNA2 (0.59) CCNA2CDK2NTRK1IGF1R
SCHEMBL12784175 0.66 CCNA2 (0.50) CCNA2CDK2NTRK1IGF1R
Hydrochloric Acid SCHEMBL1164778 0.65 CCNA2 (0.49) CCNA2CDK2NTRK1IGF1R
SCHEMBL1164333 0.64 CCNA2 (0.50) ALDH1A1KDM4ECCNA2CDK2NTRK1
SCHEMBL1164470 0.64 CCNA2 (0.46) CCNA2CDK2NTRK1IGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011019405-A1 PYRIMIDINE COMPOUNDS AS TUBERCULOSIS INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-02-17 — — WO disclosed
Send feedback